1. Home
  2. OLMA vs PKOH Comparison

OLMA vs PKOH Comparison

Compare OLMA & PKOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • PKOH
  • Stock Information
  • Founded
  • OLMA 2006
  • PKOH 1907
  • Country
  • OLMA United States
  • PKOH United States
  • Employees
  • OLMA N/A
  • PKOH N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • PKOH Industrial Specialties
  • Sector
  • OLMA Health Care
  • PKOH Industrials
  • Exchange
  • OLMA Nasdaq
  • PKOH Nasdaq
  • Market Cap
  • OLMA 299.7M
  • PKOH 282.2M
  • IPO Year
  • OLMA 2020
  • PKOH N/A
  • Fundamental
  • Price
  • OLMA $4.65
  • PKOH $18.50
  • Analyst Decision
  • OLMA Strong Buy
  • PKOH
  • Analyst Count
  • OLMA 4
  • PKOH 0
  • Target Price
  • OLMA $24.50
  • PKOH N/A
  • AVG Volume (30 Days)
  • OLMA 825.6K
  • PKOH 30.4K
  • Earning Date
  • OLMA 08-05-2025
  • PKOH 08-06-2025
  • Dividend Yield
  • OLMA N/A
  • PKOH 2.70%
  • EPS Growth
  • OLMA N/A
  • PKOH 144.68
  • EPS
  • OLMA N/A
  • PKOH 2.26
  • Revenue
  • OLMA N/A
  • PKOH $1,644,000,000.00
  • Revenue This Year
  • OLMA N/A
  • PKOH $1.80
  • Revenue Next Year
  • OLMA N/A
  • PKOH $3.97
  • P/E Ratio
  • OLMA N/A
  • PKOH $8.20
  • Revenue Growth
  • OLMA N/A
  • PKOH N/A
  • 52 Week Low
  • OLMA $2.86
  • PKOH $16.81
  • 52 Week High
  • OLMA $16.62
  • PKOH $34.50
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 52.46
  • PKOH 55.53
  • Support Level
  • OLMA $4.38
  • PKOH $18.30
  • Resistance Level
  • OLMA $5.01
  • PKOH $19.74
  • Average True Range (ATR)
  • OLMA 0.30
  • PKOH 0.76
  • MACD
  • OLMA 0.05
  • PKOH 0.17
  • Stochastic Oscillator
  • OLMA 63.64
  • PKOH 62.77

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

Share on Social Networks: